GlaxoSmithKline Intellectual Property Development Limited
发明人:
Jill Marinis ANBARI,John J. BERTIN,Jae U. JEONG
申请号:
US16488625
公开号:
US20200062735A1
申请日:
2018.02.23
申请国别(地区):
US
年份:
2020
代理人:
摘要:
Disclosed is a combination of a RIP1 kinase inhibitor compound and at least one other therapeutically active agent for use in the treatment of a RIP1 kinase mediated disease or disorder; particularly disclosed is a combination of a RIP1 kinase inhibitor compound and at least one other therapeutically active agent, wherein the at least one other therapeutically active agent is an immuno-modulator, for use in the treatment of cancer.